Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Darktrace reports continued strong top-line growth ahead of Thoma Bravo takeover

(Sharecast News) - Cybersecurity group Darktrace saw continued double-digit top-line growth in its fourth quarter, helped by decent customer growth and strong retention rates.

The company, which in April accepted a $5.3bn takeover offer from US investment firm Thoma Bravo, said revenues for the year ended 30 June are expected to come in at $689.5m, up 26.4% on the previous year with growth more or less steady from the third quarter.

Annualised recurring revenue (ARR) was up 22.7% at $782.2m, adding net ARR of $51.1m in the fourth quarter. This represented annual growth of 12.4% on a constant currency basis, and marked an an acceleration in year-over-year growth from the third quarter (+6.2%).

Darktrace added 936 net new customers over the financial year, 333 of which were added in the fourth quarter, taking its total customer base to 9,735.

Meanwhile, the net ARR retention rate was 106.6%, rising 1.3 and 2.0 percentage points from March 2024 and June 2023, respectively, "as a stabilised churn environment enabled a greater proportion of the continued improvements in upsell activity to be reflected in Darktrace's net ARR retention rate".

"We are pleased with the strong close to our financial year, which saw the third consecutive quarter of upward trajectory in year-over-year Net ARR added growth," said chief executive Poppy Gustafsson.

Gustafsson said the Thoma Bravo takeover is progressing as expected after shareholders voted overwhelmingly in favour.

"The regulatory processes are proceeding with relevant waiting periods having expired and formal and informal clearances being received in line with the anticipated timelines," Gustafsson said.

The stock was up 1% at 582.04p by 0840 BST.

Share this article

Related Sharecast Articles

Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer
(Sharecast News) - Medical technology company Smith & Nephew said on Monday that it has appointed Ajay Dhankhar as chief corporate development & strategy officer with immediate effect.
Oxford Biomedica acquires last 10pc stake in US subsidiary
(Sharecast News) - Oxford Biomedica said on Monday it has acquired the remaining 10% stake in its US subsidiary, OXB US, from Q32 Bio, bringing its ownership of the business to 100% as previously planned.
PPHE acquiring prime London site for hotel development
(Sharecast News) - PPHE Hotel Group has announced the acquisition of a prime development site near the City of London, where it plans to build its first Radisson RED select service hotel in the capital.
Norcros to end tile production in South Africa
(Sharecast News) - Norcros announced on Monday that it will shut down manufacturing at Johnson Tiles South Africa at the end of June, following the conclusion of a strategic review.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.